𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Combination chemotherapy with mitomycin, vindesine, and cisplatin for non-small cell lung cancer association of antitumor activity with initial tumor burden and treatment center

✍ Scribed by Rudolf A. Joss; Kurt Bürki; Peter Dalquen; Ernst Schatzmann; Serge Leyvraz; Franco Cavalli; Christian Ludwig; Pierre Siegenthaler; Pierre Alberto; Rolf Stahel; Eduard E. Holdener; Hansjörg Senn

Publisher
John Wiley and Sons
Year
1990
Tongue
English
Weight
878 KB
Volume
65
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combination chemotherapy with mitomycin-
Combination chemotherapy with mitomycin-C, cisplatin, and vinblastine in the treatment of non-small-cell lung cancer
✍ Niell, Harvey B. ;Griffin, John P. 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 443 KB

The drug combination of mitomycin-C, cisplatin, and vinblastine was administered to 30 patients with stage III non-small-cell lung cancer. All patients had a performance status of 50% or greater, had evaluable disease, and had not received previous chemotherapy. The overall response rate was 37% wit

Combination chemotherapy with and withou
Combination chemotherapy with and without the methanol-extracted residue of bacillus calmette-guerin (MER) in extensive non-small-cell lung cancer: A prospective randomized study for the piedmont oncology association
✍ Frederick Richards II; Virginia Howard; Anita Shore; Hyman B. Muss; Douglas R. W 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 498 KB 👁 2 views

One-hundred-three patients with extensive non-small-cell lung cancer were entered into a prospective, randomized trial to determine the value of MER as an adjuvant to chemotherapy. Patients were stratified according to histology and performance status. All patients received CCNU, methotrexate, and A